Somalogic stock.

Somalogic Inc stock performance at a glance. Check Somalogic Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. SLGC Stock Performance. USD USD; Previous close: 2.75: 2.75: Day range: 2.71 - 2.862.71 - 2.86Year range: 1 - 31 - 3Market cap: 517,198,000:

Somalogic stock. Things To Know About Somalogic stock.

SomaLogic, Inc. Warrant (SLGCW) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Renowned investor Cathie Wood’s firm ARK Invest owns 11.02 million SLGC shares for a total value of $31.95 million, according to its latest 13F filing. The imputed share price was $2.90. SLGC has a 0.2% weight in ARK Invest and a 1.12% weight in ARK Genomic Revolution ETF (ARKG). ARK owns 4.97% of the company.Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by ...SomaLogic, Inc. analysts consensus, targets, ratings and recommendations | Börse Stuttgart: 76X0 | Börse Stuttgart

The Company notes that the revised share number in such pro forma tables was determined by multiplying the updated exchange ratio (0.8426) as determined pursuant to the Business Combination Agreement by the number of issued and outstanding shares of SomaLogic common stock prior to consummation of the Business Combination, after …SomaLogic saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 7,810,000 shares, a drop of 1.1% from the previous total of 7,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment.

You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.

BOULDER — Biotechnology company SomaLogic Inc. (Nasdaq: SLGC) nearly halved its year-over-year third quarter sales, but still managed to beat Wall Street expectations as it prepares for a $1 billion merger with California-based Standard BioTools Inc. (Nasdaq: LAB).. SomaLogic develops platforms to read thousands of proteins in a …SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose - Unleashing tools to accelerate breakthroughs in humanStock analysis for SomaLogic Inc (CMIIU:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.In the process, SomaLogic will receive up to $651 million in cash from CMLS II’s IPO earnings and common stock purchases from a handful of investors, bringing its total amount of cash available ...SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools …

Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...

THIS RESTRICTED STOCK AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between SomaLogic, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the SomaLogic, Inc. 2021 Omnibus Incentive Plan, as in effect and as amended from time …

The investor owns 7.01% of the outstanding SomaLogic stock. The first SomaLogic trade was made in Q3 2021. Since then Cathie Wood bought shares six more times and sold shares on two occasions. The investor's estimated purchase price is $49.9 Million, resulting in a loss of 28%. Avg closing price. Price range. Increased shares by 2.3% (+289 …SLGC | Complete SomaLogic Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.According to 4 stock analysts, the average 12-month stock price forecast for SomaLogic stock is $4.70, which predicts an increase of 66.67%. The lowest target is $2.30 and the highest is $7.00. On average, analysts rate SomaLogic stock as a buy.SomaLogic, Inc. announced that it is extending its collaborative agreement with Novo Nordisk. As part of the agreement, which now extends into the end of 2025, Novo Nordisk will expand its use of the...Nov 22, 2023 · Why SomaLogic Stock Dived by 10% on Wednesday msn.com - October 4 at 6:56 PM: Shareholder Alert: Ademi LLP investigates whether SomaLogic, Inc. has obtained a Fair Price in its transaction with Standard BioTools benzinga.com - October 4 at 1:56 PM: SLGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of SomaLogic, Inc. SomaLogic Inc.’s SLGC, +10.78% stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to …

Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for SomaLogic stock is $4.70, which predicts an increase of …Nov 24, 2023 · 4. How much of SomaLogic stock is owned by the general public? The general public, comprising individual investors, holds a 27% stake in SomaLogic. 5. What is the significance of private equity ownership? Private equity firms hold a 6.7% stake in SomaLogic, which could influence decision-making within the company. The number of shares of Common Stock issued to Old SomaLogic stockholders was based on a deemed value of $10.00 per share after giving effect to an exchange ratio of 0.8381. Accordingly, (i) $50 million cash was paid to SomaLogic stockholders (thereby reducing the aggregate number of shares issuable under the …Sep 22, 2023 · 3. SomaLogic. Wood first bought shares of SomaLogic (SLGC 3.44%) last year for her Ark Genomic Revolution ETF. The ETF added to its position in the biotech stock earlier this month and now owns ... --SomaLogic, Inc., a leader in proteomics technology, today reported financial results for the quarter ended March 31, 2023. ... Common stock, $0.0001 par value; ...

According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.

Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year OutlookIn the process, SomaLogic will receive up to $651 million in cash from CMLS II’s IPO earnings and common stock purchases from a handful of investors, bringing its total amount of cash available ...Public companies currently own 5.5% of SomaLogic stock. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged.View the latest SomaLogic Inc. (SLGC) stock price, news, historical charts, analyst ratings and financial information from WSJ.A high-level overview of SomaLogic, Inc. (SLGC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.BOULDER — Biotechnology company SomaLogic Inc. (Nasdaq: SLGC) nearly halved its year-over-year third quarter sales, but still managed to beat Wall Street expectations as it prepares for a $1 billion merger with California-based Standard BioTools Inc. (Nasdaq: LAB).. SomaLogic develops platforms to read thousands of proteins in a …SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – and SomaLogic, Inc. (Nasdaq: SLGC), a leader in data-driven proteomics technology, today announced that the companies have set a date for their respective Special Meetings of ...View SomaLogic, Inc SLGC investment & stock information. Get the latest SomaLogic, Inc SLGC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

of SomaLogic Operating Co., Inc. and any third-party trademarks used herein are the property of their respective owners. For Research Use Only (RUO). Not intended for diagnostic or patient management purposes. Somalogic Co. Inc. is certified to ISO 9001:2015, accredited to ISO 27001:2013 and ISO 15189:2012, and is a CAP-accredited …

SLGC Sales Forecast. Next quarter’s sales forecast for SLGC is $21.05M with a range of $20.60M to $21.60M. The previous quarter’s sales results were $22.05M. SLGC beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 45.92% of the time in the same period.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...Like AMBP, SomaLogic stock experienced a much higher-than-average trading volume on Thursday. With more than 3.2 million shares traded, that was nearly three times the daily average volume for the last 30-days. The health-management technology company recently teamed up with Molecular Genomics to bring its 7,000-Plex SomaScan …Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today reported financial results for the third quarter …BOULDER, Colo., April 20, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the first quarter 2023 after market ...SomaLogic and Standard BioTools announced on Wednesday that the companies would combine in an all-stock merger. The combined company will have a pro forma equity value of over $1 billion.SomaLogic Inc.'s (SLGC) stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with ...Endpoints News — SomaLogic, co-founder of acquired company battle in court over unvested stock News • Jun 29, 2023 Benzinga — Analyst Ratings for ConcentrixSLGC Earnings Date and Information. SomaLogic last announced its earnings results on November 8th, 2023. The reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.17) by $0.05. The business earned $22.05 million during the quarter, compared to analysts' expectations of $20.45 million.SomaLogic, Inc. (NasdaqGM:SLGC) entered into a definitive agreement to acquire to acquire Standard BioTools Inc. (NasdaqGS:LAB) from Viking Global Opportunities Illiquid Investments Sub-Master LP and Viking Global Opportunities Drawdown (Aggregator) LP, managed by Viking Global Investors LP and others for approximately $570 million in a reverse merger transaction on October 4, 2023.

Real time SomaLogic (SLGC) stock price quote, stock graph, news & analysis.Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …With the stock on the backfoot, Wood evidently thinks it offers good value. Ark Invest opened a new position in SomaLogic in Q3 and snapped up 11,017,672 shares. These are currently worth over $29 ...Instagram:https://instagram. what is the best platform to trade futuresonline checking account with virtual debit cardcnvs newsmedia training course And there's no doubt that SomaLogic, Inc. (NASDAQ:SLGC) stock has had a really bad year. In that relatively short period, the share price has plunged 69%. Because SomaLogic hasn't been listed for ... best preferred stockswhat stocks to buy tomorrow Oct 4, 2023 · Standard BioTools and SomaLogic will host a joint conference call and webcast today at 8:30 a.m. ET to discuss the merger. The conference call can be accessed by dialing (800) 225-9448 within the ... 5 Wall Street analysts have issued 1-year price targets for SomaLogic's shares. Their SLGC share price targets range from $2.30 to $7.00. On average, they expect the company's share price to reach $4.26 in the next year. This suggests a possible upside of 56.0% from the stock's current price. View analysts price targets for SLGC or view top ... demo trading platforms Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …Aug 15, 2022 · SomaLogic Reports Second Quarter 2022 Financial Results. August 15, 2022 at 4:05 PM EDT. PDF Version. Second quarter 2022 revenue of $14.1 million, bringing year to date revenue to $37.1 million. Reducing 2022 revenue guidance to $80-90 million to account for ongoing variability in core service business, macroeconomic and commercial factors.